#Spatial Biology #immunofluorescence #Revolune

Revolune Launches Multiplex Immunofluorescence Reagents

In a significant development for the life sciences sector, Revolune has announced the commercial availability of its innovative multiplex immunofluorescence reagent portfolio. This marks an important step in the company's journey as they transition from a successful early access program to a full commercial launch. Designed to optimize spatial biology workflows, these reagents aim to support researchers in translational research, biopharmaceuticals, and biomarker discovery.

Spatial biology is an increasingly crucial area of research that helps scientists understand tissue architecture, disease mechanisms, and responses to treatments. Traditional multiplex analysis workflows, however, often pose challenges due to their complexity and operational demands. Established to overcome these hurdles, Revolune's goal is to make multiplex immunofluorescence more accessible for day-to-day laboratory needs.

Their reagent platform empowers researchers to visualize multiple protein biomarkers within intact tissue samples by utilizing existing primary antibodies and established laboratory practices. By simplifying assay implementation and minimizing the complexities associated with multiplexing, Revolune enables laboratories to enhance their capabilities without incurring significant additional operational costs.

Prior to hitting the market, the technology underwent thorough evaluation through an early access program involving over 30 laboratories in varied research environments, including academic institutions and biopharmaceutical firms.